The epidemiology and risk factors for breakthrough varicella in Beijing Fengtai district
Authors:
- Yuxiang YanYYYuxiang Yan
- Fen LiuFLFen Liu
- Yanxia LuoYLYanxia Luo
- Jie ZhangJZJie Zhang
- Xiaoxia PengXPXiaoxia Peng
- Yuxiang ZhangYZYuxiang Zhang
- Shujing HanSHShujing Han
- Jianzhong ZhaoJZJianzhong Zhao
- Yan HeYHYan He
- 1 September 2012
- Vol. 30 (43) , 6186-6189
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (30971178, 30670778)
- National Natural Science Foundation of China for Young Scholar (30901239)
- Funding Project for Academic Human Resources Development in Institutions of Higher Learning under the Jurisdiction of Beijing Municipality (PHR201008392)
This publication has 24 references indexed in Scilit:
- Varicella breakthrough infection and vaccine effectiveness in TaiwanVaccine, 2011
- Comparative varicella vaccine effectiveness during outbreaks in day-care centresVaccine, 2010
- Loss of Vaccine-Induced Immunity to Varicella over TimeNew England Journal of Medicine, 2007
- Varicella vaccination of children in the United States: Assessment after the first decade 1995–2005Journal of Clinical Virology, 2005
- Varicella zoster virus infections in children after the introduction of live attenuated varicella vaccineCurrent Opinion in Pediatrics, 2004
- Effectiveness of live varicella vaccineExpert Opinion on Biological Therapy, 2004
- VARICELLA VACCINEPediatric Clinics of North America, 2000
- Postlicensure study of varicella vaccine effectiveness in a day-care settingThe Pediatric Infectious Disease Journal, 1999
- Live attenuated varicella vaccineInternational Journal of Infectious Diseases, 1997
- Use of a reformulated Oka strain varicella vaccine (SmithKline Beecham Biologicals/Oka) in healthy childrenEuropean Journal of Pediatrics, 1996